LGND

Ligand Pharmaceuticals Inc.

$231.96 -1.15%

Recent alerts on LGND

All signals →

News Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know

News LGND reaches 52-week high, hitting $103.295 - Investing.com

News Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer

News Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection

News Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics

News What Makes Ligand (LGND) a New Strong Buy Stock

News Shattuck (STTK) Announces Positive Interim Data on Cancer Drug

News Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro

News Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment

News Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study

News Ensign Group (ENSG) Buys Facilities in Arizona & Colorado

News Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why

News Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?

News Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo

News Gilead (GILD) Announces Positive Interim Results on PBC Drug

News BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why

News Exelixis (EXEL) Settles Cabometyx Patent Litigation With Cipla

News Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation

News Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress

News PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

News Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies

News AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

SEC filing LGND Amends Merger Agreement with XOMA Royalty, to Form Holding Company Structure

Insider trade Sale by John W Kozarich

Insider trade Sale by John W Kozarich

Get push alerts for LGND

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS